Edition:
United Kingdom

Xenon Pharmaceuticals Inc (XENE.OQ)

XENE.OQ on NASDAQ Stock Exchange Global Market

6.15USD
18 May 2018
Change (% chg)

$-0.30 (-4.65%)
Prev Close
$6.45
Open
$6.35
Day's High
$6.60
Day's Low
$6.10
Volume
15,579
Avg. Vol
15,739
52-wk High
$6.95
52-wk Low
$2.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.209
FY 2017 Dec '17 0.02 -0.448
Sep '17 0.26 -0.430
Jun '17 0.01 -0.410
Mar '17 0.02 -0.419
FY 2016 Dec '16 0.38 -0.335
Sep '16 0.41 -0.505
Jun '16 0.41 -0.418
Mar '16 0.60 -0.227
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.05 0.09 0.01 --
Quarter Ending Sep-18 2 0.12 0.22 0.01 --
Year Ending Dec-18 3 4.34 12.98 0.00 27.33
Year Ending Dec-19 2 5.00 10.00 0.00 11.15
Earnings (per share)
Quarter Ending Jun-18 2 -0.49 -0.49 -0.49 --
Quarter Ending Sep-18 2 -0.42 -0.37 -0.47 --
Year Ending Dec-18 3 -1.48 -0.96 -1.79 -0.25
Year Ending Dec-19 2 -1.53 -1.51 -1.56 -1.38
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.06 32.75
P/E High - Last 5 Yrs. 21.51 293.32 45.73
P/E Low - Last 5 Yrs. 21.51 91.63 24.23
Beta -- 0.90 0.88
Price to Sales (TTM) 65.85 110.95 5.71
Price to Book (MRQ) 1.07 13.58 5.37
Price to Tangible Book (MRQ) 1.07 14.04 6.94
Price to Cash Flow (TTM) -- 71.44 23.33
% Owned Institutions 63.38 12.71 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -96.37 399.27 9.21
Sales (TTM) vs TTM 1 Yr. Ago -90.39 78.86 5.69
Sales - 5 Yr. Growth Rate -23.58 32.18 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 1.79 25.14 19.38
EPS (TTM) vs TTM 1 Yr. Ago -40.79 -- --
EPS - 5 Yr. Growth Rate -- 39.01 10.77
Capital Spending - 5 Yr. Growth Rate -0.77 40.31 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.19
Current Ratio (MRQ) 13.95 5.29 2.98
LT Debt to Equity (MRQ) 0.00 22.98 12.17
Total Debt to Equity (MRQ) 0.00 24.63 16.44
Interest Coverage (TTM) -9.68 -99.39 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.45
Gross Margin - 5 Yr. Avg. -- 51.16 52.21
EBITD Margin (TTM) -3,415.37 -- --
EBITD - 5 Yr. Avg -14.16 -575.09 10.96
Operating Margin (TTM) -3,496.71 -718.94 4.73
Operating Margin - 5 Yr. Avg. -18.89 -596.41 6.40
Pre-Tax Margin (TTM) -3,489.63 -693.40 5.57
Pre-Tax Margin - 5 Yr. Avg. -20.59 -599.76 6.81
Net Profit Margin (TTM) -3,489.63 -694.62 1.87
Net Profit Margin - 5 Yr. Avg. -20.59 -602.62 3.09
Effective Tax Rate (TTM) -- 22.63 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.22 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 9,318 22,637,599 847,026,665
Net Income/Employee (TTM) -325,170 2,973,819 99,639,257
Receivable Turnover (TTM) 1.92 20.17 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.01 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.07 -1.09 10.95
Return on Assets - 5 Yr. Avg. -- -0.58 12.32
Return on Investment (TTM) -55.45 1.57 14.38
Return on Investment - 5 Yr. Avg. -- 2.21 16.11
Return on Equity (TTM) -55.50 2.43 16.07
Return on Equity - 5 Yr. Avg. -- 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -88.43 -59.61 -23.58
EPS (TTM) % -34.58 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Xenon Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 57.30%
# of Holders: 39
Total Shares Held: 8,120,064
3 Mo. Net Change: -2,836,975
# New Positions: 5
# Closed Positions: 3
# Increased Positions: 9
# Reduced Positions: 14
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.